Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Photodynamic Therapy for Cervical and Vaginal Intraepithelial Neoplasia:A Multicenter Prospective Cohort Study
To investigate the efficacy and safety of photodynamic therapy (20% 5-amino-ketovalerate 630nm red light) in the treatment of cervical and vaginal intraepithelial neoplasia in women in the real world.
Age
18 - 65 years
Sex
FEMALE
Healthy Volunteers
No
Peking Unniversity Third Hospital
Beijing, Beijing Municipality, China
Start Date
February 28, 2025
Primary Completion Date
December 31, 2028
Completion Date
December 31, 2028
Last Updated
May 21, 2025
250
ESTIMATED participants
ALA-PDT
PROCEDURE
Lead Sponsor
Peking University Third Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions